Labiotech.eu interviewed Natalia Elizalde during Phacilitate’s Advanced Therapies Week congress that took place last week in Miami Beach, Florida.
In the resulting podcast Natalia perfectly describes how VIVEbiotech is a CDMO specialized in lentiviral vectors that operates according to FDA and European Medicines Agency standards serving its international clients from scratch to commercial-scale manufacturing.
She also talks about the increasing demand of viral vectors and about how VIVEbiotech plans to address this issue. About how VIVEbiotech works hard to obtain production processes that are increasingly more cost-effective, more scalable, and more automated. She also offers other interesting inputs on industry trends.
The fabulous podcast in which, in addition to Natalia, people from Orgenesis Inc., Terumo Blood and Cell Technologies, the University of Birmingham and Phacilitate participate, can be listened here: https://www.labiotech.eu/trends-news/beyond-biotech-podcast-31-advanced-therapies-week/
Thanks to Labiotech.eu for the interview!